← Evidence map

ArticleF1000Research2022

Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats.

Andry Irawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36726605